- CYCC -3.51%
All You Need to Know About Cyclacel Pharmaceuticals (CYCC) Rating Upgrade to Buy
Yahoo Finance · 1 week ago
Open | 1.6800 |
High | 1.7550 |
Low | 1.6500 |
Mkt Cap | 2.41M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 1.7100 |
52 Wk. Low | 1.3000 |
52 Wk. High | 13.2000 |
Related stocks
Company in Berkeley Heights, United States
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Berkeley Heights, New Jersey and Dundee, Scotland, developing cancer treatments. Cyclacel was founded in 1996 by David Lane, PhD. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 29k | - |
Net Income | -2.95M | - |
Diluted EPS | -2.27 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$1.43 | - |
Q1 2024 | -$4.74 | -$2.27 |
Q4 2023 | -$5.89 | -$6.23 |
S&P FuturesES=F | 5,437.75-0.75 (-0.01%) |
Dow FuturesYM=F | 38,645.00-32.00 (-0.08%) |
Nasdaq FuturesNQ=F | 19,619.50+17.00 (+0.09%) |
Tesla, Inc.TSLA | 182.47+2.92% |
Adobe Inc.ADBE | 458.74-0.25% |
871.10+12.44% |